Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Applications of genetically engineered bacteria VNP20009-M in preparation of drugs for preventing and treating lung cancer

Applications of genetically engineered bacteria VNP20009-M in preparation of drugs for preventing and treating lung cancer

US Patent 11771721 · Granted Oct 3, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of genetically engineered strain VNP20009-M in preventing and treating cance2025
Use of genetically engineered strain VNP20009-M in preventing and treating cance2025
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Use of genetically engineered bacterium of attenuated Salmonella typhimurium in 2022
Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of medicatio2021
Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of medicatio2021